![Ye Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ye Liu
Directeur Général chez
OCUMENSION THERAPEUTICS
Fortune : 32 M $ au 31/05/2026
Profil
Ye Liu currently works at Ocumension Therapeutics, as Chief Executive Officer & Executive Director from 2018.
Mr. Liu also formerly worked at Santen Pharmaceutical (China) Co. Ltd., as Chairman & General Manager from 2014 to 2018, EyePoint Pharmaceuticals, Inc., as Director from 2021 to 2024, Eisai China, Inc., as General Manager from 2009 to 2014, and Sandoz (China) Pharmaceutical Co., Ltd., as Head-Sales from 2006 to 2009.
Mr. Liu received his graduate degree in 2003 from Dalhousie University and undergraduate degree in 1993 from Zhongshan Hospital Fudan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OCUMENSION THERAPEUTICS 4,89 % | 11/09/2025 | 40 918 730 ( 4,89 % ) | 32 M $ | 31/05/2026 |
Postes actifs de Ye Liu
| Sociétés | Poste | Début |
|---|---|---|
| OCUMENSION THERAPEUTICS | Directeur Général | 01/08/2018 |
Anciens postes connus de Ye Liu
| Sociétés | Poste | Fin |
|---|---|---|
| EYEPOINT, INC. | Directeur/Membre du Conseil | 20/06/2024 |
Santen Pharmaceutical (China) Co. Ltd.
 Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Directeur Général | 01/07/2018 |
Eisai China, Inc.
 Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 01/09/2014 |
Sandoz (China) Pharmaceutical Co., Ltd.
 Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Sales & Marketing | 01/02/2009 |
Formation de Ye Liu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santen Pharmaceutical (China) Co. Ltd.
Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Health Technology |
Eisai China, Inc.
Eisai China, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Zhongshan Hospital Fudan University
 Zhongshan Hospital Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz (China) Pharmaceutical Co., Ltd.
Sandoz (China) Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Engages in the production of generic pharmaceuticals | Health Technology |
Ocumension Therapeutics
 Ocumension Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as an ophthalmic pharmaceutical platform company that develops drugs | Commercial Services |
